Statements (52)
Predicate | Object |
---|---|
gptkbp:instanceOf |
mental disorder
|
gptkbp:affects |
All Age Groups
|
gptkbp:associatedWith |
Dysregulation of HPA Axis
Neurotransmitter Imbalance Serotonin Deficiency |
gptkbp:canBe |
Moderate
Mild Severe |
gptkbp:cause |
gptkb:Suicide
Impaired Social Functioning Increased Mortality |
gptkbp:characterizedBy |
Impaired Functioning
Depressed Mood Loss of Interest |
gptkbp:class |
gptkb:DSM-5
gptkb:ICD-10 |
gptkbp:diagnosedBy |
Clinical Assessment
DSM-5 Criteria |
gptkbp:firstDescribed |
19th Century
|
https://www.w3.org/2000/01/rdf-schema#label |
Depressive Disorders
|
gptkbp:includes |
gptkb:Premenstrual_Dysphoric_Disorder
gptkb:Major_Depressive_Disorder Disruptive Mood Dysregulation Disorder Persistent Depressive Disorder |
gptkbp:mayInclude |
gptkb:Suicidal_Thoughts
Seasonal Fatigue Difficulty Concentrating Chronic Recurrent Sleep Disturbance Appetite Changes Feelings of Worthlessness Postpartum Single Episode |
gptkbp:prevalence |
Common Worldwide
|
gptkbp:relatedTo |
gptkb:Bipolar_Disorder
Anxiety Disorders |
gptkbp:riskFactor |
gptkb:Trauma
Substance Abuse Chronic Stress Genetic Predisposition Medical Illness |
gptkbp:studiedBy |
gptkb:Psychiatry
Clinical Psychology |
gptkbp:symptomDuration |
At least 2 weeks (for Major Depressive Disorder)
|
gptkbp:treatment |
gptkb:Cognitive_Behavioral_Therapy
gptkb:psychotherapy gptkb:Electroconvulsive_Therapy Antidepressant Medication |
gptkbp:bfsParent |
gptkb:DSM-5-TR
|
gptkbp:bfsLayer |
6
|